Pathophysiological mechanisms underlying a rat model of triple whammy acute kidney injury.

导出原文传递

翻译打印收藏纠错

第一作者： Laura,Prieto-García

第一单位： Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.;University of Salamanca (USAL), Department of Physiology and Pharmacology, Salamanca, Spain.;Group of Translational Research on Renal and Cardiovascular Diseases (TRECARD), Salamanca, Spain.

作者： Laura,Prieto-García ^[1] ; Laura,Vicente-Vicente ^[2] ; Víctor,Blanco-Gozalo ^[1] ; Omar,Hidalgo-Thomas ^[1] ; María C,García-Macías ^[3] ; Armin,Kurtz ^[4] ; Anita T,Layton ^[5] ; Ana B,Sanz ^[6] ; Ana I,Morales ^[7] ; Carlos,Martínez-Salgado ^[8] ; Miguel,Pericacho ^[9] ; Sandra M,Sancho-Martínez ^[2] ; Francisco J,López-Hernández ^[10]

作者单位： Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.;University of Salamanca (USAL), Department of Physiology and Pharmacology, Salamanca, Spain.;Group of Translational Research on Renal and Cardiovascular Diseases (TRECARD), Salamanca, Spain. ^[1] Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.;University of Salamanca (USAL), Department of Physiology and Pharmacology, Salamanca, Spain.;Group of Translational Research on Renal and Cardiovascular Diseases (TRECARD), Salamanca, Spain.;Group of Biomedical Research on Critical Care (BioCritic), Valladolid, Spain.;National Network for Kidney Research REDINREN, RD016/0009/0025, Instituto de Salud Carlos III, Madrid, Spain. ^[2] Centro de Investigación del Cáncer (CiC), Salamanca, Spain. ^[3] Institute of Physiology, University of Regensburg, Regensburg, Germany.;Disease and Theranostic Modeling (DisMOD) Consortium, Salamanca, Spain. ^[4] Disease and Theranostic Modeling (DisMOD) Consortium, Salamanca, Spain.;Departments of Applied Mathematics and Biology, and Schools of Computer Science and Pharmacology, University of Waterloo, Waterloo, N2L 3G1, Ontario, Canada. ^[5] National Network for Kidney Research REDINREN, RD016/0009/0025, Instituto de Salud Carlos III, Madrid, Spain.;Institute of Biomedical Research Fundación Jiménez Díaz, Madrid, Spain. ^[6] Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.;University of Salamanca (USAL), Department of Physiology and Pharmacology, Salamanca, Spain.;Group of Translational Research on Renal and Cardiovascular Diseases (TRECARD), Salamanca, Spain.;Group of Biomedical Research on Critical Care (BioCritic), Valladolid, Spain.;National Network for Kidney Research REDINREN, RD016/0009/0025, Instituto de Salud Carlos III, Madrid, Spain.;Disease and Theranostic Modeling (DisMOD) Consortium, Salamanca, Spain. ^[7] Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.;University of Salamanca (USAL), Department of Physiology and Pharmacology, Salamanca, Spain.;Group of Translational Research on Renal and Cardiovascular Diseases (TRECARD), Salamanca, Spain.;Group of Biomedical Research on Critical Care (BioCritic), Valladolid, Spain.;National Network for Kidney Research REDINREN, RD016/0009/0025, Instituto de Salud Carlos III, Madrid, Spain.;Disease and Theranostic Modeling (DisMOD) Consortium, Salamanca, Spain.;Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León (IECSCYL), Soria, Spain. ^[8] Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.;University of Salamanca (USAL), Department of Physiology and Pharmacology, Salamanca, Spain.;National Network for Kidney Research REDINREN, RD016/0009/0025, Instituto de Salud Carlos III, Madrid, Spain.;Disease and Theranostic Modeling (DisMOD) Consortium, Salamanca, Spain. ^[9] Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain. flopezher@usal.es.;University of Salamanca (USAL), Department of Physiology and Pharmacology, Salamanca, Spain. flopezher@usal.es.;Group of Translational Research on Renal and Cardiovascular Diseases (TRECARD), Salamanca, Spain. flopezher@usal.es.;Group of Biomedical Research on Critical Care (BioCritic), Valladolid, Spain. flopezher@usal.es.;National Network for Kidney Research REDINREN, RD016/0009/0025, Instituto de Salud Carlos III, Madrid, Spain. flopezher@usal.es.;Disease and Theranostic Modeling (DisMOD) Consortium, Salamanca, Spain. flopezher@usal.es.;Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León (IECSCYL), Soria, Spain. flopezher@usal.es. ^[10]